| Drug Name: | Iproniazid (54-92-2) |
|---|---|
| PubChem ID: | 3748 |
| SMILES: | CC(C)NNC(=O)C1=CC=NC=C1 |
| InchiKey: | NYMGNSNKLVNMIA-UHFFFAOYSA-N |
| Therapeutic Category: | Antidepressive Agents, Central Nervous System Agents, Enzyme Inhibitors, Monoamine Oxidase Inhibitors, Psychotropic Drugs |
| Molecular Weight (dalton) | : | 179.223 |
| LogP | : | 0.7244 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 3 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 54.02 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Cardiomegaly | MetaADEDB |
| Depressive Disorder | MetaADEDB |
| Epilepsy Tonic-Clonic | MetaADEDB |
| Hepatitis | MetaADEDB |
| Necrosis | MetaADEDB |